HTA Debates in 2018-2019

• Japan to Roll Out Cost-Effectiveness Assessment Scheme in April
  February 21, 2019

• Importance of Non-ICER Factors in Cost-Effectiveness Assessment Starting to Resonate with Chuikyo Reps
  February 7, 2019

• Tough CEA Rules for Cost-Based Method Products Targeting Imports: EFPIA Japan Vice Chair
  February 7, 2019

• Japan, US, European Trade Groups Give Opinions on Govt’s CEA Proposal: Chuikyo
  February 7, 2019

• PhRMA Takes Issue with Japan Govt’s Overreliance on ICER, Proposes Point-Based Appraisal Framework
  February 5, 2019

• MHLW Unveils Outline of Cost-Effective Assessment Scheme: Chuikyo
  January 24, 2019

• CEFP Finalizes Govt Reform Timeline Urging FY2019 Debate on “Economic Evaluations” for Reimbursement Decisions
  December 21, 2018

• Chuikyo Snubs Industry’s Call to Exclude Listed Products from CEA Scope
  December 20, 2018

• PhRMA, EFPIA Pitch Enhanced Appraisal Model for Japan HTA Plan; Chuikyo Reps Acknowledge ICER Limitations
  December 20, 2018

• Govt’s Draft Reform Timeline Prods MHLW to Discuss Use of “Economic Evaluations” in Reimbursement Decisions in FY2019
  December 11, 2018

• National Institute of Public Health to Play Core Role in CEA Public Analysis Process
  December 6, 2018

• Chuikyo Agrees on 3 ICER Thresholds for “Tiered” CEA Price Adjustment Model; Industry Hearing Slated by Year-End
  December 6, 2018

• MHLW Eyes Drastic Change to Cost Effective Analysis Flow, Enhanced Discussions Upfront
  November 22, 2018

• MHLW Proposes Quarterly Product Selections, Price Tweaks for CEA Scheme: Chuikyo
  November 22, 2018

• MOF Panel Urges Govt to Use Economic Evaluations for Reimbursement Decisions: FY2019 Budget Recommendation
  November 21, 2018

• Health Economist Calls for Robust Appraisal Process in Japan CEA System
  November 20, 2018

• Experts Say ICER Deduction Unscientific, MHLW Proposes Different Thresholds for Cancer and Orphan Drugs
  November 8, 2018

• Chuikyo Supports Price Raise Rules for Cost-Effective Products
  November 8, 2018

• MHLW Pitches “Tiered Model” for CEA Price Tweak, but Faces Chuikyo Opposition
  November 8, 2018

• Limit CEA Application to Premium-Given Drugs with Big Sales: EFPIA Japan Officials
  October 29, 2018

ページ